The Desmoplastic Reaction and Intrahepatic Cholangiocarcinoma Progression: CAFs, Select Molecular Drivers, and Prognostic Implications

Mar 22, 2021 5:00pm ‐ Mar 22, 2021 5:30pm

Coffee Break

Mar 22, 2021 5:30pm ‐ Mar 22, 2021 5:40pm

Targeting the Tumor Microenvironment for Cholangiocarcinoma Therapy

Mar 22, 2021 5:40pm ‐ Mar 22, 2021 6:10pm

Short Talk: p-Ezrin (Thr567) Synergizes with Akt Signaling to Accelerate Yap Mediated Cholangiocarcinogenesis but Correlates with a Favorable Prognosis in Human Intrahepatic Cholangiocarcinoma(ICC) Patients

Mar 22, 2021 6:10pm ‐ Mar 22, 2021 6:25pm

Short Talk: SQSTM1/p62 Inhibits whereas Nrf2 Promotes Tumorigenesis by Inducing Cell Population Remodeling and Metabolic Reprograming in Mouse Livers with mTORC1 Activation and Defective Autophagy

Mar 22, 2021 6:25pm ‐ Mar 22, 2021 6:40pm

Short Talk: Requirement of Hippo Signaling Cascade during AXIN1 Mutation Driven Hepatocarcinogenesis

Mar 22, 2021 6:40pm ‐ Mar 22, 2021 6:55pm

Short Talk: Long Non-Coding RNA NIHCOLE Promotes the DNA Damage Repair of Hepatocellular Carcinoma Cells

Mar 22, 2021 6:55pm ‐ Mar 22, 2021 7:10pm

Liver Cancer Risk-Predictive Molecular Biomarkers Specific to Clinico-Epidemiological Contexts

Mar 23, 2021 9:00am ‐ Mar 23, 2021 9:30am

Hepatobiliary Cancer Biomarkers and Molecular Subtypes

Mar 23, 2021 9:00am ‐ Mar 23, 2021 12:10pm

Liquid Biopsy in Hepatobiliary Cancers

Mar 23, 2021 9:30am ‐ Mar 23, 2021 10:00am